These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2270435)

  • 1. Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts.
    Garred P; Hetland G; Mollnes TE; Stoervold G
    Scand J Immunol; 1990 Nov; 32(5):555-60. PubMed ID: 2270435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
    Johnson E; Hetland G
    Scand J Immunol; 1991 Jun; 33(6):667-71. PubMed ID: 2047760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex.
    Hetland G; Johnson E; Falk RJ; Eskeland T
    Scand J Immunol; 1986 Oct; 24(4):421-8. PubMed ID: 3764345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro.
    Hetland G; Johnson E; Aasebø U
    Scand J Immunol; 1986 Nov; 24(5):603-8. PubMed ID: 3787189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.
    Guc D; Gulati P; Lemercier C; Lappin D; Birnie GD; Whaley K
    Rheumatol Int; 1993; 13(4):139-46. PubMed ID: 8310205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human alveolar macrophages synthesize active complement components C6, C7, and C8 in vitro.
    Pettersen HB; Johnson E; Hetland G
    Scand J Immunol; 1987 Jun; 25(6):567-70. PubMed ID: 3602933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of complement by alveolar macrophages from patients with sarcoidosis.
    Pettersen HB; Johnson E; Mollnes TE; Garred P; Hetland G; Osen SS
    Scand J Immunol; 1990 Jan; 31(1):15-23. PubMed ID: 1689072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of flow cytometry to detect the biosynthesis of complement components.
    Hetland G; Garred P; Mollnes TE; Størvold G
    J Immunol Methods; 1991 Jul; 140(2):167-71. PubMed ID: 2066563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads.
    Berge V; Johnson E; Høgåsen K
    APMIS; 1997 Jan; 105(1):17-24. PubMed ID: 9063496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of the third and fifth complement components by isolated human lung cells.
    Rothman BL; Merrow M; Bamba M; Kennedy T; Kreutzer DL
    Am Rev Respir Dis; 1989 Jan; 139(1):212-20. PubMed ID: 2912341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the membrane attack mechanism of complement.
    Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
    J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro.
    Langeggen H; Berge KE; Macor P; Fischetti F; Tedesco F; Hetland G; Berg K; Johnson E
    APMIS; 2001 Jan; 109(1):73-8. PubMed ID: 11297196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.
    Würzner R; Schulze M; Happe L; Franzke A; Bieber FA; Oppermann M; Götze O
    Complement Inflamm; 1991; 8(5-6):328-40. PubMed ID: 1724954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of soluble C3 and C9 neoepitopes by human alveolar macrophages in vitro.
    Pettersen HB; Johnson E; Mollnes TE; Garred P
    Scand J Immunol; 1988 Oct; 28(4):431-4. PubMed ID: 2461585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the membrane attack complex of complement (MAC) on erythrocytes from monocyte-produced terminal complement components.
    Hetland G; Johnson E; Eskeland T
    Scand J Immunol; 1987 Jun; 25(6):571-7. PubMed ID: 3602934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.
    Xia P; Jordon RE; Geoghegan WD
    J Clin Invest; 1988 Dec; 82(6):1939-47. PubMed ID: 2461964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.